PC
ARRY

PointState Capital’s Array Biopharma Inc ARRY Stock Holding History

PointState Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-973,700
Closed -$15.9M – 209
2018
Q1 		$15.9M Buy
973,700
+563,900
+138% +$9.03M 0.17% 82
2017
Q4 		$5.25M Sell
409,800
-1,475,300
-78% -$16.8M 0.05% 112
2017
Q3 		$23.2M Buy
+1,885,100
New +$17.5M 0.2% 83
2017
Q2 		– Sell
-1,983,800
Closed -$17.7M – 187
2017
Q1 		$17.7M Buy
+1,983,800
New +$21.1M 0.18% 78

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

PointState Capital's ARRY Position: Q2 2018 in Review

PointState Capital sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 973,700 shares — an estimated $15.9M sold.

PointState Capital first reported a position in ARRY in Q1 2017 and held it in 4 quarters. The position peaked at $23.2M in Q3 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • PointState Capital reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • PointState Capital sold 973,700 Array Biopharma Inc shares in Q2 2018, an estimated $15.9M.
  • PointState Capital first reported a position in Array Biopharma Inc in Q1 2017 and held it in 4 quarters.
  • PointState Capital's Array Biopharma Inc position peaked at $23.2M in Q3 2017.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on PointState Capital's 13F filing for Q2 2018, filed 14 Aug 2018.